Publisher： Karger
E-ISSN： 1421-9794|47|3|38-43
ISSN： 0009-3157
Source： Chemotherapy, Vol.47, Iss.3, 2001-09, pp. : 38-43
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Latest Industry Information on the Safety Profile of Levofloxacin in the US
Chemotherapy, Vol. 47, Iss. 3, 2001-09 ,pp. :
Access to resources
Recommend
Post-Marketing Surveillance of the Safety of Levofloxacin in Japan
Chemotherapy, Vol. 53, Iss. 2, 2007-01 ,pp. :
Access to resources
New Insights in the Treatment by Levofloxacin
Chemotherapy, Vol. 50, Iss. 1, 2004-08 ,pp. :
Pharmacodynamics and Pharmacokinetics of Levofloxacin
Chemotherapy, Vol. 46, Iss. 1, 2000-05 ,pp. :